stockrowTakeda Pharmaceutical Co. (TAK) vs Teva Pharmaceutical Industries Ltd. (TEVA)
- Takeda Pharmaceutical Co. TAK 21.25 +0.90%
- Teva Pharmaceutical Industries Ltd. TEVA 41.73 −0.29%
Takeda Pharmaceutical Co. and Teva Pharmaceutical Industries Ltd. are both Drug Manufacturers Specialty & Generic companies. Takeda Pharmaceutical Co. is the larger, with a market value of $67.7B against $48.7B — 1.4× the size. Takeda Pharmaceutical Co. trades at the lower P/E: 32.0× against 92.6×. Teva Pharmaceutical Industries Ltd. grew revenue faster over the last twelve months: 2.71% against 0.66%. Takeda Pharmaceutical Co. has the higher net margin (7.12% vs 2.94%) and the lower return on invested capital (0.00% vs 4.09%). Across the 21 metrics below, Takeda Pharmaceutical Co. leads on 13 and Teva Pharmaceutical Industries Ltd. on 8.
Valuation
Profitability
| Metric | TAK | TEVA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 65.85% | 53.51% | 53.51% |
| Operating margin | 11.61% | 7.84% | 0.00% |
| Net margin | 7.12% | 2.94% | (2.45%) |
| Free cash flow margin | 0.00% | 7.71% | 0.00% |
| Return on equity | 0.00% | 6.65% | (0.80%) |
| Return on assets | 0.00% | 1.27% | (1.67%) |
| Return on invested capital | 0.00% | 4.09% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack